Efficacy of CS-758, a Novel Triazole, against Experimental Fluconazole-Resistant Oropharyngeal Candidiasis in Mice

The therapeutic efficacy of CS-758, a novel triazole, was evaluated against experimental murine oropharyngeal candidiasis induced by Candida albicans with various susceptibilities to fluconazole. Against infections induced by strains with various susceptibilities to fluconazole, the efficacy of fluc...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Kamai, Yasuki, Kubota, Mikie, Fukuoka, Takashi, Kamai, Yoko, Maeda, Naoyuki, Hosokawa, Tsunemichi, Shibayama, Takahiro, Uchida, Katsuhisa, Yamaguchi, Hideyo, Kuwahara, Shogo
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2003
Matèries:	Experimental Therapeutics
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC151753/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12543666/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.2.601-606.2003
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!